-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Nonapeptide-1, also known as Melanostatin 2, is a synthetic peptide that has been studied for its potential use in a variety of applications, including as a skin whitener and as an anti-aging agent.
The production process for nonapeptide-1 involves a number of steps, including the synthesis of the peptide sequence, purification of the synthesized peptide, and finally, formulation and packaging of the product.
The first step in the production process for nonapeptide-1 is the synthesis of the peptide sequence.
This is typically accomplished using solid phase peptide synthesis (SPPS) or liquid phase peptide synthesis (LPPS) methods.
SPPS involves the use of a solid support, such as a resin or a bead, on which the peptide is synthesized.
LPPS, on the other hand, involves the use of a liquid solvent in which the peptide is synthesized.
Both methods have their advantages and disadvantages, and the choice of method will depend on the specific requirements of the production process.
Once the peptide sequence has been synthesized, it is typically purified to remove any impurities that may have been introduced during the synthesis process.
This can be accomplished using a number of different techniques, such as high performance liquid chromatography (HPLC) or gel filtration chromatography.
These techniques involve the use of a chromatographic matrix, such as a column packed with beads or a membrane, to separate the peptide from any impurities.
After the peptide has been purified, it is typically formulated into a final product.
This may involve the addition of other ingredients, such as preservatives or stabilizers, to improve the stability and shelf life of the product.
The formulated product is then packaged in a suitable container, such as a bottle or an aerosol can, for use.
In conclusion, the production process for nonapeptide-1 involves the synthesis of the peptide sequence, purification of the synthesized peptide, and finally, formulation and packaging of the product.
This process is designed to ensure that the final product is of the highest quality and is safe and effective for use.
